Considering the extensive role of PIN1 in the carcinogenic process, a meta-analysis was performed that included all eligible case-control studies, to estimate the overall cancer risk associated with the PIN1 promoter polymorphism (−842 G>C) and to quantify the potential heterogeneity between the studies. The gene discussed is PIN1; the disease is cancer.